Clinical Trial Update: Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing enhancement of anti-tetanus vaccine response after autologous stem cell transplantation in plasma cell myeloma; study terminated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasma Cell Myeloma

Snippet

Sponsor: University of Nebraska | Conditions: Plasma Cell Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2024-03-12